March 14, 2025 04:28 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
In a setback for Donald Trump, US judge orders federal agencies to rehire fired workers: Report | 'We will thwart conspiracies hatched by Centre': Revanth Reddy on delimitation exercise | Chennai doctor, his wife along with two sons die by suicide due to huge debt: Cops | Amid language debate, Tamil Nadu drops rupee symbol in state budget | Scientist killed in assault by neighbour over parking argument in Mohali | British woman tourist raped in Delhi hotel by man she befriended on social media | Gold smuggling case: Court restrains media from publishing, telecasting defamatory statements against Ranya Rao | Trump warns Putin of 'devastating' financial impacts if Russia blocks Ukraine ceasefire | 'People are going to Russia right now as we speak: Donald Trump on Ukraine war ceasefire talks | Pakistani army claims to have freed all hostages in passenger train siege; 28 personnel killed
AstraZeneca vaccine
Image Credit: AstraZeneca Twitter Handle

UK to offer AstraZeneca vaccine's alternative to people below 30 yrs over concerns of blood clots

| @indiablooms | Apr 08, 2021, at 04:27 am

London/IBNS: Amidst concerns over rare blood clot disorders resulting in deaths of people following inoculation, a government committee in the UK has said that those below 30 years of age should be offered an alternative to the AstraZeneca Covid vaccine.

While 19 people have died in the UK from rare blood clots after receiving the jab, about 79 such cases have been reported in the country.

"Adults who are aged 18 to 29 years old who do not have an underlying health condition... should be offered an alternative Covid-19 vaccine in preference to the AstraZeneca vaccine, where such an alternative vaccine is available," Wei Shen Lim of the Joint Committee on Vaccination and Immunisation, said at a press conference.

The AstraZeneca vaccine is being manufactured by India's Pune-based Serum Institute in collaboration with Oxford University under the name of "Covishield".

It is one of the two vaccines approved by India's drug regulator for emergency use in January this year.

The World Health Organization (WHO) is also expected to update its safety assessment on the AstraZeneca vaccine soon, informed an official on Tuesday.

Initially, UK had not linked the blood clot disorder with the vaccine's jabs but changed its stance as increasing cases were reported.

European Union's drug regulator had said it had found a "possible link" between the AstraZeneca vaccine and the clotting disorder.

Earlier in March, several European countries like Denmark, Norway, Austria, Netherlands and Iceland had temporarily suspended the use of Oxford-AstraZeneca's Covid-19 vaccine over concerns about patients suffering from post-jab blood clots.
 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.